Grifols earned 162 million euros in the third quarter, 28% more than the previous year. The Catalan blood-derived products giant has been boosted by its biopharmaceutical business and increased its revenue in the period by 8.4% year-on-year at constant exchange rates, reaching 2.040 billion euros. With this result, according to what the multinational reported in a statement, the turnover for the first nine months of the year rose to 5.614 billion euros, 4.6% more than a year earlier. Profit between January and September, for its part, reached 390 million euros, 28.4% more.

"There is plenty of financing available." The CEO of CaixaBank, Gonzalo Gortázar, defended this Friday that the obstacle to housing development in Spain does not come from the entities' capacity to grant mortgages, but rather from the construction deficit and the rise in prices that the sector has been suffering for years. He stated this at the press conference held in Valencia to present the company's results up to September, a period in which the bank earned 4.962 billion euros, 12.9% more than last year.

The Volkswagen Group is going through a deep crisis, and this is confirmed by the numbers the company presented this Thursday. During the first nine months of the year, the net result of the German parent company of Seat has plummeted, going from profits of 3.405 billion last year to losses of 2.720 billion this year. The operating profit—which comes strictly from the company's main activity, without being impacted by taxes or financial costs—also fell sharply (-98.7%) and stands at 71 million, compared to 5.408 billion a year ago. "The results make one thing clear: we cannot afford to waste time and we must act with speed and decisiveness," said the Group's CFO and COO, Arno Antlitz.

BBVA continues to break profit records in an environment favorable to the banking sector. During the first nine months of the year, the Basque-originated entity reached a profit of 9.066 billion euros, 13.6% more than in the same period last year. The group presided over by Carlos Torres attributes the figures to the good performance of its recurring income, divided between the net interest margin—the difference between income and financial costs—and banking fees. In this sense, the gross margin until September—the indicator that reflects an entity's total turnover—reached 32.072 billion euros, 16.3% more in year-on-year terms.

Banco Santander closed the third quarter of the year with a total profit of 12.405 billion euros, 20% more than in the first nine months of the previous fiscal year, a figure that represents a new record for the entity in this period. The increase is largely due to the net capital gain of 1.895 billion euros generated by the sale of its subsidiary in Poland, an operation that was completed at the beginning of this 2026.

New semester of green numbers for CaixaBank, which has closed the first six months of 2026 with a net profit of 3,203 million euros, 8.5% more than in the same period last year. This was detailed this Wednesday by the company's CEO, Gonzalo Gortázar, during the presentation of the entity's results held in Valencia.

Grifols earned 227 million euros during the first half of this year, 28.2% more than in the same period of the previous fiscal year. The Catalan multinational of plasma-derived medicines attributes the improvement, in large part, to the evolution of its biopharma division, its main source of income. According to the results published this Tuesday to the National Securities Market Commission (CNMV), the turnover of this area reached 3,148 million euros by June, 5.4% more year-on-year at constant exchange rates.

Mango has sold 7.2% more in the first six months of this year than in the same period last year, after discounting inflation: the Catalan brand has invoiced 1,852 million euros between January and June.

"Sabadell's revenues are going like a shot". Marc Armengol presented this Friday his first accounts as CEO of the Catalan bank, in which the entity obtained a net profit of 971 million euros in the first half of the year, 0.5% less than the previous year. It should be noted that the results still include the contribution of the British subsidiary TSB, which changed hands in May and now belongs to Santander.

After obtaining record profits of 2,023 million euros last year, Naturgy's profits continue to rise in 2026. During this first semester, the energy company's earnings have increased by 5.9% compared to the same period in 2025, reaching 1,215 million, as reported this Wednesday to the National Securities Market Commission (CNMV).

The Viena restaurant chain closed the 2025 financial year with improved sales, in a context it considers "especially challenging" for the sector. According to the results released this Tuesday, the company recorded a turnover of 91.9 million euros in 2025, 1.8% more than the previous year. The improvement in operating results has made it possible to increase profitability on sales – obtained by dividing net profit by net sales – to 14.4%, above the figures for the previous financial year.

Hipra broke its business record in 2025. The Girona-based pharmaceutical company invoiced 516 million euros last year, its all-time high, and it is the first time it has exceeded 500 million in revenue in more than five decades of history. This represents an increase of 17% compared to the figures for 2024, in line with the company's aspirations to "grow above the market". On these sales, Hipra has achieved a profit close to 54 million euros, and has managed to reduce its debt to 145.5 million.

Ryanair completes fiscal year 2026 with a 40% jump in profit, to a record figure of 2.26 billion euros. The low-cost airline has earned 15.54 billion euros between April 2025 and March this year, 11% more than in the previous fiscal year. The economic improvements have been recorded following a 4% increase in passengers, who exceeded 208 million in the 12 recorded months.

The Catalan pharmaceutical company Almirall closed the first quarter of 2026 with a drop in profits despite the good performance of its main business –the dermatology products segment– and a general increase in sales. According to the accounts published this Monday to the National Securities Market Commission (CNMV), the company registered a net profit of 15.3 million euros, 29.2% less than in the same period of the previous year.

The distrust of investors with Grifols once again punishes the company's stock during earnings season. After the Catalan pharmaceutical company published its quarterly accounts at the close of Thursday's market, with a 22% increase in profit, up to 73 million euros, it opened Friday's stock session in a clear downward trend. Around twenty minutes to eleven in the morning, the Catalan multinational's shares are the worst in the selective index, with a decrease of more than 4%. Around midday, however, the analysis firm Moody's improved its assessment of the company's debt, painting a positive immediate future. With this new reading, the stock has rebounded slightly. After one in the afternoon, it lowered the value by about 2%, to 8.98 euros.

Grifols earned 73 million euros in the first quarter, 21.9% more than in the same period last year. As reported by the Catalan multinational in plasma-derived medicines, between January and March it registered a turnover of 1,700 million euros.

Uriach reinforces its commitment within the natural and self-care products health segment and consolidates its business model in Europe. After a decade marked by a dozen acquisitions across the Old Continent, the Catalan pharmaceutical company closed the year 2025 with a 3% increase in sales, approaching the 500 million euros it had set as a goal when it launched its strategic plan in 2015. Although the improvement falls short of the figures recorded the previous year –revenue in 2024 increased by 54%–, the company acknowledges that the past year has been characterized by a "complex" context after several years of high-growth markets.

Fluidra starts 2026 slowed by currency effects. Despite having closed a first quarter of "good performance", the company chaired by Eloi Planes has registered a slight decrease in net profit, over 4%, to 46 million euros, due to the weakness of the dollar. It should be recalled that the Catalan listed company concentrates more than 40% of its business in the United States and, therefore, the exchange rate with the North American currency affects the declared accounts. In fact, as indicated in a statement, earnings at constant exchange rates would rise by 6.4% compared to the same period in 2026. The same would happen with revenue, which remains stable at 564 million, but rises by 5.4% with a comparable dollar value.

Another historic year for CaixaBank. The bank, chaired by Tomàs Muniesa and with Gonzalo Gortázar as CEO, closed 2015 with a record profit of €5.891 billion, 1.8% higher than the previous year, according to the results published this Friday with the Spanish National Securities Market Commission (CNMV). In the last quarter, the bank's profit was €1.494 billion, 3.4% higher than in the previous quarter. "It has been a very positive year for the bank, and therefore also positive for the Spanish economy," stated the bank's CEO, Gonzalo Gortázar, during the press conference presenting the results in Valencia, where the bank maintains its headquarters – "and there are no plans to change it in the coming years" despite the Gortázar incident. "We have exceeded the expectations for the first year of the strategic plan," he noted.

BBVA has turned the page on the failed hostile takeover bid for Banc Sabadell, flexing its muscles with record results through September. The financial institution posted a net profit of €7.978 billion in the first nine months of 2025, representing a 4.7% increase compared to the same period last year, as reported this Thursday morning to the Spanish National Securities Market Commission (CNMV). These results are the first announced since the outcome of the takeover bid for Sabadell. in which only 25% of the share capital BBVA accepted the offer, which definitively derailed the operation. "Whatever we do, we do it to create value for our shareholders [...], and the best thing we can do is close the chapter on the takeover bid," said the bank's CEO, Onur Genç, at a press conference this Thursday. "We're not going to make excuses," he said. In any case, Genç regretted that it was a "missed opportunity" for both entities, as well as for investors and customers.